VanHimbergen Robert M 4

What Happened

• Robert M. VanHimbergen, Executive Vice President and CFO of Elanco Animal Health Inc., was granted 7.803 deferred stock units on January 23, 2026. The units are reported at $24.40 each, for a total reported value of $190. This transaction is an award/grant (derivative unit), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-01-23; Filing date: 2026-01-27.
• Transaction type/code: Award/Grant (A); derivative instrument: deferred stock units (DSUs).
• Quantity and price: 7.803 DSUs @ $24.40 each; total value $190.
• Shares owned after transaction: not specified in the filing.
• Footnotes:
  • F1: Each deferred stock unit represents the right to receive one share of common stock or the cash equivalent.
  • F2: DSUs settle in cash or shares following termination of employment or during a specified future year per the Executive Deferral and Stock Match Plan.
• The filing does not include a late-filing code; the report was filed four days after the transaction date.

Context

• Deferred stock units are a form of compensation that convert to stock or cash later and are commonly used for executive deferral and retention; they do not represent an immediate market purchase or sale.
• Because this is a small-value award ($190), it appears to be a routine grant/deferral under a compensation plan rather than a significant insider investment signal.